KNTE Annual CFI
$109.87 M
+$116.70 M+1708.62%
01 December 2023
Summary:
As of February 5, 2025, KNTE annual cash flow from investing activities is $109.87 million, with the most recent change of +$116.70 million (+1708.62%) on December 1, 2023. During the last 3 years, it has risen by +$141.58 million (+446.49%).KNTE Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KNTE Quarterly CFI
$22.70 M
-$19.93 M-46.75%
01 December 2023
Summary:
As of February 5, 2025, KNTE quarterly cash flow from investing activities is $22.70 million, with the most recent change of -$19.93 million (-46.75%) on December 1, 2023. Over the past year, it has dropped by -$19.93 million (-46.75%).KNTE Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KNTE TTM CFI
$109.87 M
+$5.13 M+4.90%
01 December 2023
Summary:
As of February 5, 2025, KNTE TTM cash flow from investing activities is $109.87 million, with the most recent change of +$5.13 million (+4.90%) on December 1, 2023. Over the past year, it has increased by +$5.13 million (+4.90%).KNTE TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KNTE Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1708.6% | -46.8% | +4.9% |
| 3 y3 years | +446.5% | -46.8% | +4.9% |
| 5 y5 years | - | -46.8% | +4.9% |
KNTE Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high | -59.0% | -3.0% |
Kinnate Biopharma Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $109.87 M(-1708.6%) | $22.70 M(-46.8%) | $109.87 M(+4.9%) |
| Sept 2023 | - | $42.63 M(-491.7%) | $104.74 M(+32.5%) |
| June 2023 | - | -$10.88 M(-119.6%) | $79.06 M(-30.2%) |
| Mar 2023 | - | $55.42 M(+215.5%) | $113.22 M(-1757.7%) |
| Dec 2022 | -$6.83 M(-96.2%) | $17.57 M(+3.6%) | -$6.83 M(-69.0%) |
| Sept 2022 | - | $16.96 M(-27.2%) | -$22.06 M(+8.9%) |
| June 2022 | - | $23.28 M(-136.0%) | -$20.25 M(-73.2%) |
| Mar 2022 | - | -$64.63 M(-2864.3%) | -$75.57 M(-58.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$180.57 M(+469.5%) | $2.34 M(-87.5%) | -$180.57 M(-15.7%) |
| Sept 2021 | - | $18.76 M(-158.6%) | -$214.26 M(-8.1%) |
| June 2021 | - | -$32.04 M(-81.1%) | -$233.25 M(+15.9%) |
| Mar 2021 | - | -$169.63 M(+441.1%) | -$201.31 M(+534.9%) |
| Dec 2020 | -$31.71 M(<-9900.0%) | -$31.35 M(>+9900.0%) | -$31.71 M(+8732.6%) |
| Sept 2020 | - | -$226.00 K(+117.3%) | -$359.00 K(+169.9%) |
| June 2020 | - | -$104.00 K(+258.6%) | -$133.00 K(+358.6%) |
| Mar 2020 | - | -$29.00 K | -$29.00 K |
| Dec 2019 | $0.00 | - | - |
FAQ
- What is Kinnate Biopharma annual cash flow from investing activities?
- What is the all time high annual CFI for Kinnate Biopharma?
- What is Kinnate Biopharma annual CFI year-on-year change?
- What is Kinnate Biopharma quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Kinnate Biopharma?
- What is Kinnate Biopharma quarterly CFI year-on-year change?
- What is Kinnate Biopharma TTM cash flow from investing activities?
- What is the all time high TTM CFI for Kinnate Biopharma?
- What is Kinnate Biopharma TTM CFI year-on-year change?
What is Kinnate Biopharma annual cash flow from investing activities?
The current annual CFI of KNTE is $109.87 M
What is the all time high annual CFI for Kinnate Biopharma?
Kinnate Biopharma all-time high annual cash flow from investing activities is $109.87 M
What is Kinnate Biopharma annual CFI year-on-year change?
Over the past year, KNTE annual cash flow from investing activities has changed by +$116.70 M (+1708.62%)
What is Kinnate Biopharma quarterly cash flow from investing activities?
The current quarterly CFI of KNTE is $22.70 M
What is the all time high quarterly CFI for Kinnate Biopharma?
Kinnate Biopharma all-time high quarterly cash flow from investing activities is $55.42 M
What is Kinnate Biopharma quarterly CFI year-on-year change?
Over the past year, KNTE quarterly cash flow from investing activities has changed by -$19.93 M (-46.75%)
What is Kinnate Biopharma TTM cash flow from investing activities?
The current TTM CFI of KNTE is $109.87 M
What is the all time high TTM CFI for Kinnate Biopharma?
Kinnate Biopharma all-time high TTM cash flow from investing activities is $113.22 M
What is Kinnate Biopharma TTM CFI year-on-year change?
Over the past year, KNTE TTM cash flow from investing activities has changed by +$5.13 M (+4.90%)